8-K: Scienture Secures $3.5M Debt, Repays Prior Loan

Scienture Holdings, Inc. secured a new $3.91 million senior secured promissory note from Streeterville Capital, LLC, yielding $3.5 million in net proceeds, primarily used to repay an existing $2.66 million defaulted loan.

Summary

• Scienture Holdings, Inc. (Debtor) entered into a Note Purchase Agreement with Streeterville Capital, LLC (Secured Party) on October 14, 2025.
• A senior secured promissory note with a principal amount of $3,911,111.11 was issued.
• The note includes an original issue discount (OID) of $391,111.11 and $20,000 for the Lender's transaction costs, resulting in net proceeds of $3,500,000.
• The net proceeds were used to fully repay the outstanding balance of the NVK Loan, which totaled $2,656,250 as of September 30, 2025.
• The NVK Loan, originally due September 8, 2025, had been extended to December 8, 2025, on October 10, 2025, with NVK waiving existing Events of Default.
• Consideration for the NVK extension included a $25,000 amendment fee, legal fees, a $25,000 maturity extension fee, and the issuance of 250,000 common shares to NVK.
• The new note matures seven months from issuance (May 14, 2026) and accrues interest at 9% per annum, compounded daily.
• The note is secured by a first-position security interest in all assets of Scienture Holdings, Inc. and its subsidiary, Scienture, LLC, including intellectual property.
• Remaining net proceeds will be used for working capital, debt repayment, capital expenditures, product development, and general corporate purposes.

Sentiment

Score: 2

Explanation: The company is in a precarious financial position, evidenced by the default on a prior loan and the necessity of securing highly expensive, heavily collateralized debt with restrictive covenants. While new capital was raised, the terms are highly unfavorable and indicate significant financial distress and limited options.

Positives

• Successfully refinanced an existing loan that was in default, avoiding immediate acceleration by NVK Finance LLC.
• Secured $3,500,000 in net proceeds, providing capital for operations and strategic initiatives beyond debt repayment.
• The new note allows for prepayment in whole or in part without penalty.

Negatives

• Incurred significant costs for the new financing, including a $391,111.11 Original Issue Discount and $20,000 in transaction expenses, reducing net proceeds.
• The new promissory note carries a high annual interest rate of 9%, with a default interest rate of 22%.
• Issued 250,000 shares of common stock to NVK Finance LLC as consideration for extending the previous loan, leading to shareholder dilution.
• The new debt is secured by a first-position security interest in substantially all assets of both Scienture Holdings, Inc. and its subsidiary, Scienture, LLC, including intellectual property, limiting future financing flexibility.
• Faces restrictive covenants, including limitations on future debt or equity issuances ("Restricted Issuance") without the Lender's prior written consent.
• Mandatory prepayment clauses require 25% of proceeds from future fundraising or financing transactions to be applied to the note, potentially hindering growth capital.
• Was already in default on its previous NVK loan, indicating ongoing financial challenges.

Risks

• High Debt Burden & Cost: The new note has a high interest rate (9%) and significant upfront costs (OID, transaction fees), increasing the financial burden. Default interest is 22%.
• Asset Encumbrance: All assets of Scienture Holdings, Inc. and its subsidiary, Scienture, LLC, including intellectual property, are pledged as collateral, severely limiting the ability to secure future financing.
• Restrictive Covenants: Covenants in the Purchase Agreement, such as restrictions on "Restricted Issuances" and granting new liens, could impede strategic flexibility and future capital raises.
• Mandatory Prepayment: The requirement to use 25% of future financing proceeds for mandatory prepayment could hinder the company's ability to raise sufficient growth capital.
• Event of Default Triggers: A wide range of events, including failure to meet SEC filing deadlines, delisting from Nasdaq, money judgments over $250,000, or even a non-management supported proxy filing, can trigger default and immediate acceleration of the note.
• Dilution Risk: The issuance of 250,000 shares to NVK Finance LLC for the loan extension indicates a willingness to dilute existing shareholders to manage debt.
• Ongoing Litigation: The company and its subsidiary are involved in two pending legal proceedings, which could result in significant financial liabilities.
• Financial Distress Indicators: The need to amend and extend a defaulted loan, followed by securing new high-cost, highly secured debt, suggests underlying financial instability.

Future Outlook

The company intends to utilize the remaining net proceeds from the new financing for working capital, debt repayment, capital expenditures, product development, and other general corporate purposes. It also commits to timely SEC filings and maintaining its Nasdaq listing.

Management Comments

• We acknowledge that this Note is an unconditional, valid, binding and enforceable obligation of Borrower not subject to offset, deduction or counterclaim of any kind.
• We knowingly, voluntarily and irrevocably waive any rights of offset, counterclaim, defense or recoupment it now has or may have hereafter against Lender.
• We have reviewed the Arbitration Provisions carefully, consulted with legal counsel about such provisions (or waived its right to do so), understands that the Arbitration Provisions are intended to allow for the expeditious and efficient resolution of any dispute hereunder, agrees to the terms and limitations set forth in the Arbitration Provisions, and that Company will not take a position contrary to the foregoing representations.

Industry Context

This financing event reflects a common challenge for smaller or financially distressed public companies in securing capital. The high cost of debt, extensive collateralization, and restrictive covenants are typical of 'last resort' financing from non-traditional lenders when access to conventional capital markets is limited. The need to refinance a defaulted loan suggests the company operates in a competitive or capital-intensive sector where maintaining liquidity is critical.

Legal Proceedings

• Eat Well Investment Group Inc. v. TRxADE Health, Inc. (n/k/a Scienture Holdings, Inc.), et.al. Case No. 8:25cv35, filed 01/06/2025, in the U.S. District Court, Florida Middle District.
• Kesin Pharma Corporation v. Scienture, Inc. (n/k/a Scienture, LLC) Case No. 2:25cv1386, filed 03/11/2025, in the U.S. District Court, New York Eastern District.

Stakeholder Impact

• Shareholders: Significant dilution from the issuance of 250,000 shares to NVK. Future dilution risk from potential mandatory prepayments from equity raises. Share price likely to be negatively impacted by the high cost of debt and restrictive covenants.
• Creditors (Streeterville Capital): Holds a first-position security interest in all company and subsidiary assets, providing strong protection for their investment.
• Creditors (NVK Finance LLC): Repaid in full, resolving their previous loan and default situation.
• Employees/Operations: The new capital provides liquidity for working capital and product development, potentially stabilizing operations in the short term.

Next Steps

• Utilize remaining net proceeds for working capital, debt repayment, capital expenditures, product development, and other general corporate purposes.
• File a prospectus supplement within ten days following the issuance of 250,000 shares to NVK Finance LLC to register their resale.
• Maintain timely SEC filings and the listing of common stock on a national exchange.
• Manage ongoing legal proceedings.

Key Dates

Recommendation

The company's financial position appears highly distressed. The need to refinance a defaulted loan with new, extremely expensive, and heavily collateralized debt (9% interest, 22% default rate, significant OID, all assets pledged) indicates a severe lack of access to conventional capital. The issuance of 250,000 shares for a loan extension, coupled with mandatory prepayment clauses from future financings, suggests ongoing dilution and limited growth prospects. Restrictive covenants further constrain strategic flexibility. The existing legal proceedings add another layer of uncertainty. These factors collectively point to significant financial risk and a challenging path forward, making the stock a strong sell for seasoned investors.

Keywords

Scienture Holdings, SCNX, Secured Promissory Note, Debt Financing, Streeterville Capital, NVK Finance, Loan Repayment, SEC Filing, 8-K, Corporate Finance, Financial Restructuring, Intellectual Property Security, Asset-Backed Loan, High-Yield Debt, Covenants, Default Risk, Working Capital, Nasdaq Listing